Envista (NVST) P/E (2019 - 2026)
Envista (NVST) P/E from Sep 18, 2019 to Jul 21, 2026. The TTM Envista (NVST) P/E is 65.20. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Envista (NVST)
| Year | P/E | Change |
|---|---|---|
| 2026 | 65.20 | -15.78% |
| 2025 | 77.41 | -2711.42% |
| 2024 | -2.96 | -114.30% |
| 2023 | 20.74 | -3.13% |
| 2022 | 21.41 | +0.34% |
| 2021 | 21.33 | -87.00% |
| 2020 | 164.08 | +589.73% |
| 2019 | 23.79 | N/A |
Comparison Envista (NVST) P/E with competitors
Envista (NVST) P/E is 65.20.
| Ticker | Name | P/E | Upside |
|---|---|---|---|
| MHUA | Meihua International Medical Technologies Co Ltd - Class A | 0.22 | -99.66% |
| EMBC | Embecta Corp | 1.69 | -97.41% |
| SOLV | Solventum Corp | 9.49 | -85.44% |
| ZJYL | Jin Medical International Ltd | 12.75 | -80.45% |
| PDEX | Pro-Dex Inc (co) | 15.22 | -76.66% |
| RMD | Resmed Inc | 19.04 | -70.79% |
| UTMD | Utah Medical Products Inc | 20.76 | -68.16% |
| ATR | Aptargroup Inc | 21.65 | -66.80% |
| ALGN | Align Technology Inc | 30.29 | -53.54% |
| HOLX | Hologic Inc | 30.86 | -52.66% |
| MMSI | Merit Medical Systems Inc | 31.15 | -52.23% |
| STVN | Stevanato Group Spa | 31.25 | -52.06% |
| LMAT | Lemaitre Vascular Inc | 36.34 | -44.26% |
| ALC | Alcon Inc | 41.51 | -36.32% |
| ISRG | Intuitive Surgical Inc | 46.43 | -28.79% |
| BDX | Becton Dickinson & Company | 46.93 | -28.01% |
| WST | West Pharmaceutical Services Inc | 47.41 | -27.29% |
| NEPH | Nephros Inc | 50.00 | -23.31% |
| COO | Cooper Companies Inc | 58.98 | -9.54% |
| NNNN | Anbio Biotechnology - Class A | 62.20 | -4.60% |
| BAX | Baxter International Inc | 72.66 | +11.44% |
| ICUI | ICU Medical Inc | 84.82 | +30.10% |
| RGEN | Repligen Corp | 162.20 | +148.78% |
| WRBY | Warby Parker Inc - Class A | 318.30 | +388.21% |